Anthera Pharmaceuticals Inc - Company & Market Research Reports

Following a company allows Research and Markets to customize your experience and provide personalized recommendations.

Anthera Pharmaceuticals is a biopharmaceutical company that specializes in products to treat serious diseases associated with inflammation and autoimmune diseases. The company has two product candidates in development. Sollpura is a biotechnology-derived pancreatic enzyme replacement therapy for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis. Blisibimod is a BAFF inhibitor for the potential treatment of IgA nephropathy. The company was founded in 2004 and is headquartered in Hayward, California.

From
From
From
From
From
From
Competitor Landscape: Lupus - Product Thumbnail Image

Competitor Landscape: Lupus

  • Report
  • 53 Pages
From
Ascites Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Ascites Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 110 Pages
From
From
From
From
From
Global Biopharma Outlook 2011 - Product Thumbnail Image

Global Biopharma Outlook 2011

  • Report
  • 391 Pages
From
From
Loading Indicator
adroll